लोड हो रहा है...
PTIP associates with Artemis to dictate DNA repair pathway choice
PARP inhibitors (PARPis) are being used in patients with BRCA1/2 mutations. However, doubly deficient BRCA1(−/−)53BP1(−/−) cells or tumors become resistant to PARPis. Since 53BP1 or its known downstream effectors, PTIP and RIF1 (RAP1-interacting factor 1 homolog), lack enzymatic activities directly...
में बचाया:
| में प्रकाशित: | Genes Dev |
|---|---|
| मुख्य लेखकों: | , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Cold Spring Harbor Laboratory Press
2014
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4265673/ https://ncbi.nlm.nih.gov/pubmed/25512557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/gad.252478.114 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|